Case number 2018-1925
OSI Pharmaceuticals, LLC v. Apotex Inc. > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Apr 23, 2021 | 0 | OSI PHARMACEUTICALS, LLC v. APOTEX INC. [OPINION - PRECEDENTIAL] [precedential] (0) |
| Nov 25, 2019 | 63 | Mandate issued to the United States Patent and Trademark Office. Service as of this date by the Clerk of Court. [652173] [JAB] [Entered: 11/25/2019 02:55 PM] (0) |
| Oct 4, 2019 | 61 | OPINION filed for the court by Newman, Circuit Judge; Taranto, Circuit Judge and Stoll, Circuit Judge. Precedential Opinion. [640235] [JAB] [Entered: 10/04/2019 10:18 AM] (0) |
| Oct 4, 2019 | 62 | JUDGMENT. REVERSED. Terminated on the merits after oral argument. COSTS: Costs taxed against Appellee(s). Mandate to issue in due course. For information regarding costs, petitions for rehearing, and petitions for writs of certiorari click here. [640239] [JAB] [Entered: 10/04/2019 10:20 AM] (0) |
| Aug 22, 2019 | 59 | Citation of Supplemental Authority pursuant to Fed. R. App. P. 28(j) for Intervenor US. Service: 08/22/2019 by email, US mail. [630172] [18-1925] [Dennis Fan] [Entered: 08/22/2019 11:04 AM] (0) |
| Aug 22, 2019 | 60 | RESPONSE of Appellant OSI Pharmaceuticals, LLC to the supplemental authority [58] filed by Intervenor US, supplemental authority [59] filed by Intervenor US. Service: 08/22/2019 by email, US mail. [630293] [18-1925] [Amy Wigmore] [Entered: 08/22/2019 02:21 PM] (0) |
| Aug 1, 2019 | 58 | Citation of Supplemental Authority pursuant to Fed. R. App. P. 28(j) for Intervenor US. Service: 08/01/2019 by email, US mail. [625111] [18-1925] [Dennis Fan] [Entered: 08/01/2019 09:27 AM] (0) |
| Jul 29, 2019 | 56 | MOTION of Appellant OSI Pharmaceuticals, LLC to withdraw counsel Tracey C. Allen [Consent: unopposed]. Service: 07/29/2019 by email, US mail. [623957] [18-1925] [Tracey Allen] [Entered: 07/29/2019 09:23 AM] (0) |
| Jul 29, 2019 | 57 | **TEXT ONLY** ORDER granting motion to withdraw attorney Tracey C. Allen [56] filed by Appellant OSI Pharmaceuticals, LLC. Service as of this date by the Clerk of Court. This order has been issued without an attached document and is official and binding. [624207] [JAB] [Entered: 07/29/2019 03:08 PM] (0) |
| Jun 6, 2019 | 55 | Submitted after ORAL ARGUMENT by Mr. Thomas Saunders for OSI Pharmaceuticals, LLC, Mr. William Blake Coblentz for Apotex Inc., Apotex Holdings Inc., Apotex Corp. and Apotex Pharmaceuticals Holdings Inc. and Mr. Dennis Fan for US. Panel: Judge: Newman , Judge: Taranto , Judge: Stoll. [612003] [JCP] [Entered: 06/06/2019 10:47 AM] (0) |
| May 15, 2019 | 54 | Response to notice of oral argument from the Appellant OSI Pharmaceuticals, LLC. [607453] [18-1925] [Thomas Saunders] [Entered: 05/15/2019 10:43 AM] (0) |
| May 15, 2019 | 53 | Response to notice of oral argument from the Appellees Apotex Corp., Apotex Holdings Inc., Apotex Inc. and Apotex Pharmaceuticals Holdings Inc.. [607433] [18-1925] [Barry Golob] [Entered: 05/15/2019 10:21 AM] (3) |
| May 8, 2019 | 52 | Response to notice of oral argument from the Intervenor US. [605767] [18-1925] [Dennis Fan] [Entered: 05/08/2019 10:16 AM] (2) |
| Apr 25, 2019 | 51 | RESPONSE of Appellant OSI Pharmaceuticals, LLC to the supplemental authority [50] filed by Intervenor US. Service: 04/25/2019 by email, US mail. [602954] [18-1925] [Amy Wigmore] [Entered: 04/25/2019 02:30 PM] (3) |
| Apr 22, 2019 | 50 | Citation of Supplemental Authority pursuant to Fed. R. App. P. 28(j) for Intervenor US. Service: 04/22/2019 by email, US mail. [602091] [18-1925] [Dennis Fan] [Entered: 04/22/2019 04:19 PM] (22) |
| Apr 22, 2019 | 49 | NOTICE OF ORAL ARGUMENT. Panel: 1906K. Case scheduled Jun 06, 2019 10:00 a.m. at the United States Court of Appeals for the Federal Circuit (Howard T. Markey National Courts Building, 717 Madison Place, NW Washington, DC 20439), Courtroom 402. Response to Notice of Oral Argument due: 05/15/2019. Please review the attached Notice. The response to notice of oral argument form can be found here. The Oral Argument Guide can be found here. [601951] [JAB] [Entered: 04/22/2019 01:34 PM] (2) |
| Feb 20, 2019 | 48 | Notice from Intervenor US regarding conflicts with oral argument. None. Service: 02/20/2019 by email, US mail. [587517] [18-1925] [Dennis Fan] [Entered: 02/20/2019 04:39 PM] (0) |
| Feb 15, 2019 | 47 | Notice from Appellees Apotex Corp., Apotex Holdings Inc., Apotex Inc. and Apotex Pharmaceuticals Holdings Inc. regarding conflicts with oral argument. None. Service: 02/15/2019 by email. [586495] [18-1925] [Barry Golob] [Entered: 02/15/2019 03:15 PM] (0) |
| Feb 13, 2019 | 46 | Notice from Appellant OSI Pharmaceuticals, LLC regarding conflicts with oral argument. None. Service: 02/13/2019 by email. [585590] [18-1925] [Amy Wigmore] [Entered: 02/13/2019 12:36 PM] (0) |
| Feb 13, 2019 | 45 | 6 paper copies of the Opening Response Brief [36] received from Appellees Apotex Corp., Apotex Holdings Inc., Apotex Inc. and Apotex Pharmaceuticals Holdings Inc.. [585530] [CJF] [Entered: 02/13/2019 10:28 AM] (0) |
| Feb 12, 2019 | 44 | 6 paper copies of the Appendix Brief [39] received from Appellant OSI Pharmaceuticals, LLC. [585140] [CJF] [Entered: 02/12/2019 10:59 AM] (0) |
| Feb 12, 2019 | 43 | 6 paper copies of the Reply Brief [37] received from Appellant OSI Pharmaceuticals, LLC. [585125] [CJF] [Entered: 02/12/2019 10:25 AM] (0) |
| Feb 11, 2019 | 42 | 6 paper copies of the Intervenor Brief [35] received from Intervenor US. [584974] [CJF] [Entered: 02/11/2019 04:24 PM] (0) |
| Feb 11, 2019 | 41 | Outstanding paper copies of all briefs and appendices must be submitted within five business days from the date of issuance of this notice. See Fed. Cir. R. 25(c)(1). [584822] [MJL] [Entered: 02/11/2019 01:40 PM] (0) |
| Feb 11, 2019 | 40 | Notice to Advise of Scheduling Conflicts. Arguing counsel must advise of, and show good cause for, any scheduling conflicts during the upcoming court session months listed in the attached notice. The notice of conflict with oral argument is due on or before 02/19/2019. The Response to Notice to Advise of Scheduling Conflicts can be found here. The Oral Argument Guide can be found here. [584821] [MJL] [Entered: 02/11/2019 01:37 PM] (1) |
| Jan 23, 2019 | 39 | MODIFIED ENTRY: APPENDIX FILED for OSI Pharmaceuticals, LLC. Number of Pages: 681. Service: 01/23/2019 by email. [580083]--[Edited 01/29/2019 by MJL - compliance review complete] [Amy Wigmore] [Entered: 01/23/2019 10:41 AM] (681) |
| Jan 16, 2019 | 38 | Notice of Appointment of New Solicitor for the U.S. Patent and Trademark Office. Service: 01/22/2019 by clerk. [579573] [17-2257, 17-2304, 17-2323, 17-2593, 17-2621, 18-1047, 18-1048, 18-1070, 18-1105, 18-1163, 18-1302, 18-1311, 18-1368, 18-1385, 18-1438, 18-1443, 18-1485, 18-1489, 18-1659, 18-1768, 18-1772, 18-1876, 18-1883, 18-1901, 18-1925, 18-1933, 18-1944, 18-1968, 18-2000, 18-2031, 18-2032, 18-2069, 18-2082, 18-2106, 18-2170, 18-2236, 18-2271, 18-2329, 19-1049, 19-1117, 19-1334] [MJL] [Entered: 01/22/2019 10:12 AM] (1) |
| Jan 16, 2019 | 37 | MODIFIED ENTRY: REPLY BRIEF FILED for Appellant OSI Pharmaceuticals, LLC. Number of Pages: 24. Service: 01/16/2019 by email. [578679]--[Edited 01/29/2019 by MJL - compliance review complete] [Amy Wigmore] [Entered: 01/16/2019 03:44 PM] (32) |
| Dec 26, 2018 | 36 | MODIFIED ENTRY: BRIEF FILED for Appellees Apotex Corp., Apotex Holdings Inc., et al. Number of Pages: 51. Service: 12/26/2018 by email. Unless ordered otherwise, any responsive deadline runs from the date of service of this brief. See FCR 31. [574532]--[Edited 01/09/2019 by MJL - compliance review complete] [Barry Golob] [Entered: 12/26/2018 04:03 PM] (61) |
| Dec 26, 2018 | 35 | MODIFIED ENTRY: BRIEF FILED for Intervenor US. Number of Pages: 40. Service: 12/26/2018 by email. [574394]--[Edited 01/09/2019 by MJL - compliance review complete] [Dennis Fan] [Entered: 12/26/2018 10:06 AM] (50) |
| Nov 19, 2018 | 34 | Entry of appearance for Farheena Y. Rasheed as of counsel for Intervenor US. Service: 11/19/2018 by email. [566304] [18-1925] [Farheena Rasheed] [Entered: 11/19/2018 01:33 PM] (2) |
| Nov 19, 2018 | 33 | Entry of appearance for Thomas W. Krause as of counsel for Intervenor US. Service: 11/19/2018 by email. [566301] [18-1925] [Thomas Krause] [Entered: 11/19/2018 01:31 PM] (1) |
| Nov 19, 2018 | 32 | Entry of appearance for Joseph Matal as of counsel for Intervenor US. Service: 11/19/2018 by email. [566299] [18-1925] [Joseph Matal] [Entered: 11/19/2018 01:25 PM] (2) |
| Nov 14, 2018 | 31 | ORDER filed. The motion [29] is granted. The revised official caption is reflected in the order; The stay is lifted. The appellees’ and the intervenor’s response briefs are due within 40 days from the date of filing of this order. Service: 11/14/2018 by clerk. [564872] [NL] [Entered: 11/14/2018 02:56 PM] (2) |
| Nov 13, 2018 | 30 | Entry of appearance for Dennis Fan as principal counsel for United States. Service: 11/13/2018 by email. [564408] [18-1925] [Dennis Fan] [Entered: 11/13/2018 01:42 PM] (1) |
| Nov 5, 2018 | 28 | Entry of appearance for Katherine Twomey Allen as principal counsel for United States. Service: 11/05/2018 by email. [562520] [18-1925] [Katherine Allen] [Entered: 11/05/2018 10:55 AM] (2) |
| Nov 5, 2018 | 27 | Entry of appearance for Scott R. McIntosh as of counsel for United States. Service: 11/05/2018 by email. [562514] [18-1925] [Scott McIntosh] [Entered: 11/05/2018 10:49 AM] (1) |
| Nov 5, 2018 | 29 | MOTION of United States for leave to intervene [Consent: unopposed]. Service: 11/05/2018 by email. [562523] [18-1925] [Katherine Allen] [Entered: 11/05/2018 10:57 AM] (4) |
| Oct 15, 2018 | 26 | 6 paper copies of the Opening Brief [25] received from Appellant OSI Pharmaceuticals, LLC. [556899] [CJF] [Entered: 10/15/2018 09:38 AM] (0) |
| Oct 4, 2018 | 24 | ORDER filed. Notice of OSI's constitutional challenge [23] is hereby certified to the Attorney General. No later than 30 days from the date of filing of this order, the Attorney General is directed to inform this court whether the United States intends to intervene in this appeal. The proceedings in the above-captioned appeal are stayed. Service: 10/04/2018 by clerk. [555033] [LMS] [Entered: 10/04/2018 04:09 PM] (2) |
| Oct 1, 2018 | 25 | BRIEF FILED for Appellant OSI Pharmaceuticals, LLC [22]. Number of Pages: 51. Service: 10/01/2018 by email. The paper copies of the brief should be received by the court on or before 10/18/2018. [556359] [MJL] [Entered: 10/11/2018 12:31 PM] (159) |
| Oct 1, 2018 | 23 | Notice from Appellant OSI Pharmaceuticals, LLC Notice of Constitutional Challenge Pursuant To Fed. R. App. P. 44(a). Service: 10/01/2018 by email. [553749] [18-1925] [Amy Wigmore] [Entered: 10/01/2018 02:34 PM] (3) |
| Oct 1, 2018 | 22 | TENDERED from Appellant OSI Pharmaceuticals, LLC. Title: OPENING BRIEF. Service: 10/01/2018 by email. [553747] [18-1925] [Amy Wigmore] [Entered: 10/01/2018 02:28 PM] (159) |
| Sep 27, 2018 | 21 | Entry of appearance for Tracey Cote Allen as of counsel for Appellant OSI Pharmaceuticals, LLC. Service: 09/27/2018 by email. [552976] [18-1925] [Tracey Allen] [Entered: 09/27/2018 12:47 PM] (2) |
| Jul 18, 2018 | 20 | ORDER granting motion to extend time to file brief [17]. OSI Pharmaceuticals, LLC's brief is due 10/01/2018. Service: 07/18/2018 by clerk. [536890] [NL] [Entered: 07/18/2018 04:59 PM] (2) |
| Jul 17, 2018 | 19 | REPLY of Appellant OSI Pharmaceuticals, LLC to response filed by Appellees, Doc. No [18]. Service: 07/17/2018 by email. [536672] [18-1925] [Thomas Saunders] [Entered: 07/17/2018 07:21 PM] (5) |
| Jul 16, 2018 | 18 | RESPONSE of Appellees Apotex Corp., Apotex Inc., Apotex Holdings Inc. and Apotex Pharmaceuticals Holdings Inc. to the motion to extend time to file brief [17] filed by Appellant OSI Pharmaceuticals, LLC. Service: 07/16/2018 by email. [536194] [18-1925] [Aaron Lukas] [Entered: 07/16/2018 05:00 PM] (6) |
| Jul 12, 2018 | 17 | MOTION of Appellant OSI Pharmaceuticals, LLC to extend the time to 10/01/2018 to file the Principal Brief. [Consent: opposed]. Service: 07/12/2018 by email. [535568] [18-1925] [Thomas Saunders] [Entered: 07/12/2018 05:32 PM] (11) |
| Jun 19, 2018 | 16 | Certified list from the United States Patent and Trademark Office. Service: 06/18/2018 by email. Appellant's brief is due 08/17/2018. [530448] [CFT] [Entered: 06/19/2018 09:11 AM] (84) |
| May 21, 2018 | 15 | CLERK'S OFFICE QUALITY CONTROL MESSAGE: re:attorney entry of appearance Docket No. [8], ERROR: The firm address included on the entry of appearance (EOA) for William Blake Coblentz does not match the information in the attorney's user account. CORRECTION: Pursuant to FCR 47.3(c)(1), please update as needed to ensure the contact information on the EOA and in the user account matches. ECF account information may be updated at www.pacer.gov, or counsel may file an amended EOA. THIS MESSAGE IS FOR INFORMATIONAL PURPOSES ONLY. [523311] [CFT] [Entered: 05/21/2018 03:05 PM] (0) |
| May 21, 2018 | 14 | Docketing Statement for the Appellant OSI Pharmaceuticals, LLC. Service: 05/21/2018 by email. [523299] [18-1925] [Amy Wigmore] [Entered: 05/21/2018 02:53 PM] (4) |
| May 21, 2018 | 13 | Certificate of Interest for the Appellant OSI Pharmaceuticals, LLC. Service: 05/21/2018 by email. [523298] [18-1925] [Amy Wigmore] [Entered: 05/21/2018 02:52 PM] (3) |
| May 21, 2018 | 12 | Entry of appearance for Kevin M. Yurkerwich as of counsel for Appellant OSI Pharmaceuticals, LLC. Service: 05/21/2018 by email. [523296] [18-1925] [Kevin Yurkerwich] [Entered: 05/21/2018 02:50 PM] (2) |
| May 21, 2018 | 11 | Entry of appearance for Amanda L. Major as of counsel for Appellant OSI Pharmaceuticals, LLC. Service: 05/21/2018 by email. [523294] [18-1925] [Amanda Major] [Entered: 05/21/2018 02:48 PM] (2) |
| May 21, 2018 | 10 | Entry of appearance for Aaron S. Lukas as of counsel for Appellees Apotex Inc., Apotex Corp., Apotex Pharmaceuticals Holdings Inc. and Apotex Holdings Inc.. Service: 05/21/2018 by email. [523292] [18-1925] [Barry Golob] [Entered: 05/21/2018 02:47 PM] (2) |
| May 21, 2018 | 9 | Entry of appearance for Emily R. Whelan as of counsel for Appellant OSI Pharmaceuticals, LLC. Service: 05/21/2018 by email. [523291] [18-1925] [Emily Whelan] [Entered: 05/21/2018 02:46 PM] (2) |
| May 21, 2018 | 8 | Entry of appearance for William Blake Coblentz as of counsel for Appellees Apotex Inc., Apotex Corp., Apotex Holdings Inc. and Apotex Pharmaceuticals Holdings Inc.. Service: 05/21/2018 by email. [523290] [18-1925] [Barry Golob] [Entered: 05/21/2018 02:45 PM] (2) |
| May 21, 2018 | 7 | Entry of appearance for Thomas G. Saunders as of counsel for Appellant OSI Pharmaceuticals, LLC. Service: 05/21/2018 by email. [523288] [18-1925] [Thomas Saunders] [Entered: 05/21/2018 02:44 PM] (2) |
| May 21, 2018 | 6 | Entry of appearance for Kerry B. McTigue as of counsel for Appellees Apotex Inc., Apotex Corp., Apotex Pharmaceuticals Holdings Inc. and Apotex Holdings Inc.. Service: 05/21/2018 by email. [523284] [18-1925] [Barry Golob] [Entered: 05/21/2018 02:44 PM] (2) |
| May 21, 2018 | 5 | Entry of appearance for Amy K. Wigmore as principal counsel for Appellant OSI Pharmaceuticals, LLC. Service: 05/21/2018 by email. [523280] [18-1925] [Amy Wigmore] [Entered: 05/21/2018 02:42 PM] (2) |
| May 21, 2018 | 4 | Docketing Statement for the Appellees Apotex Inc., Apotex Corp., Apotex Pharmaceuticals Holdings Inc. and Apotex Holdings Inc.. Service: 05/21/2018 by email. [523274] [18-1925] [Barry Golob] [Entered: 05/21/2018 02:37 PM] (4) |
| May 21, 2018 | 3 | Certificate of Interest for the Appellees Apotex Inc., Apotex Corp., Apotex Pharmaceuticals Holdings Inc. and Apotex Holdings Inc.. Service: 05/21/2018 by email. [523269] [18-1925] [Barry Golob] [Entered: 05/21/2018 02:35 PM] (3) |
| May 21, 2018 | 2 | Entry of appearance for Barry P. Golob as principal counsel for Appellees Apotex Inc., Apotex Corp., Apotex Pharmaceuticals Holdings Inc. and Apotex Holdings Inc.. Service: 05/21/2018 by email. [523260] [18-1925] [Barry Golob] [Entered: 05/21/2018 02:32 PM] (2) |
| May 7, 2018 | 1 | Appeal docketed. Received: 05/04/2018. [519480] Entry of Appearance due 05/21/2018. Certificate of Interest due 05/21/2018. Docketing Statement due 05/21/2018. Certified List due 06/18/2018. [CFT] [Entered: 05/07/2018 09:06 AM] (78) |
